Table I.
Characteristic | Cases (n=1,310) | Controls (n=1,259) | ||
---|---|---|---|---|
N | % | n | % | |
Age (years) | ||||
< 50 | 102 | 7.8 | 105 | 8.3 |
50–59 | 522 | 39.9 | 519 | 41.2 |
60–69 | 542 | 41.4 | 491 | 39.0 |
70–74 | 144 | 11.0 | 144 | 11.4 |
Family history of prostate cancer | ||||
No | 1,027 | 78.4 | 1,118 | 88.8 |
Yes | 283 | 21.6 | 141 | 11.2 |
Number of PSA testsa | ||||
None | 290 | 22.1 | 445 | 35.4 |
1–2 | 321 | 24.5 | 239 | 19.0 |
3–4 | 244 | 18.6 | 153 | 12.2 |
≥ 5 | 392 | 29.9 | 225 | 17.9 |
Missing | 63 | 4.8 | 197 | 15.7 |
PSA | ||||
0 – 3.9 | 179 | 13.7 | 1,169 | 92.9 |
4 – 9.9 | 721 | 55.0 | 74 | 5.9 |
10 – 19.9 | 189 | 14.4 | 14 | 1.1 |
20+ | 118 | 9.0 | 2 | 0.2 |
Missing | 103 | 7.9 | ||
Stage of disease | ||||
Local | 1,020 | 77.9 | ||
Regional | 257 | 19.6 | ||
Distant | 33 | 2.5 | ||
Gleason score | ||||
Low (2–4) | 70 | 5.3 | ||
Moderate [5–7 (3+4)] | 1,034 | 78.9 | ||
High [7 (4+3), 8–10] | 202 | 15.4 | ||
Missing | 4 | 0.3 | ||
Cancer aggressiveness | ||||
Less aggressive b | 870 | 66.4 | ||
More aggressive c | 440 | 33.6 |
PSA tests done in the 5 years before reference date.
Local stage, and Gleason score 2–6 or 7 (3 + 4), and diagnostic serum PSA <20 ng/mL.
Regional/distant stage, or Gleason score 7 (4 + 3) or 8–10, or serum PSA ≥20 ng/mL.